2024 ASCO Gastrointestinal Cancers Symposium ASCO GI 2024: Radioligand Therapy for Gastroenteropancreatic Neuroendocrine Tumors
2024 ASCO Gastrointestinal Cancers Symposium ASCO GI 2024: ctDNA as a Predictive Biomarker for Patients With Colon Cancer
Breast Cancer Addition of Sacituzumab Govitecan to Pembrolizumab in Advanced Triple-Negative Breast Cancer